HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masafumi Takiguchi Selected Research

HLA-A*26:03 antigen

11/2005Identification and characterization of HIV-1 epitopes presented by HLA-A*2603: comparison between HIV-1 epitopes presented by A*2601 and A*2603.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masafumi Takiguchi Research Topics

Disease

26Infections
01/2022 - 01/2002
14Acquired Immunodeficiency Syndrome (AIDS)
05/2020 - 06/2003
9Disease Progression
11/2021 - 05/2008
6HIV Infections (HIV Infection)
01/2019 - 11/2002
3Bites and Stings (Sting)
01/2021 - 01/2019
3Virus Diseases (Viral Diseases)
11/2016 - 06/2006
3Vaccinia
11/2005 - 06/2003
2Hepatitis
06/2006 - 08/2003
1Shock
01/2021
1Persistent Infection
10/2018
1Ulcerative Colitis
12/2017
1Takayasu Arteritis (Arteritis, Takayasu's)
12/2017
1Viremia
05/2014
1Leukemia
03/2009
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
05/2008
1Hepatocellular Carcinoma (Hepatoma)
06/2006
1Rheumatoid Arthritis
08/2005
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2005
1Necrosis
08/2003
1Blister (Bulla)
08/2003
1Chronic Hepatitis (Chronic Active Hepatitis)
01/2002

Drug/Important Bio-Agent (IBA)

24EpitopesIBA
01/2021 - 06/2003
15VaccinesIBA
05/2020 - 06/2003
14HLA-B Antigens (HLA-B)IBA
11/2021 - 01/2005
9Peptides (Polypeptides)IBA
01/2022 - 11/2002
9HLA-A Antigens (HLA-A)IBA
01/2019 - 01/2002
7HLA-C Antigens (HLA-C)IBA
01/2022 - 07/2015
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2022 - 11/2005
4LigandsIBA
01/2021 - 11/2016
4HLA-B*52:01 antigenIBA
01/2021 - 01/2017
4HLA-B57 antigenIBA
01/2020 - 04/2009
4AIDS VaccinesIBA
04/2019 - 03/2009
3T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2021 - 12/2012
2Rilpivirine (TMC-278)IBA
10/2017 - 10/2016
2Antiviral Agents (Antivirals)IBA
02/2012 - 05/2007
1Proteasome Endopeptidase Complex (Proteasome)IBA
12/2019
1CCR5 Receptors (CCR5 Receptor)IBA
01/2019
1AntigensIBA
01/2019
1InterferonsIBA
01/2019
1Immunodominant EpitopesIBA
01/2019
1cyclic guanosine monophosphate-adenosine monophosphateIBA
01/2019
1Long Noncoding RNAIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
10/2018
1T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
01/2017
1KIR ReceptorsIBA
11/2016
1SolutionsIBA
04/2016
1Biomarkers (Surrogate Marker)IBA
11/2015
1Reverse Transcriptase InhibitorsIBA
07/2015
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
07/2015
1HLA-B*07 antigenIBA
05/2014
1HLA-A*24:02 antigenIBA
02/2012
1Phosphotransferases (Kinase)IBA
10/2010
1Human Immunodeficiency Virus ProteinsIBA
04/2009
1EnzymesIBA
06/2006
1Telomerase (Telomerase Reverse Transcriptase)IBA
06/2006
1HLA-A*26:03 antigenIBA
11/2005
1Leukocyte Immunoglobulin-like Receptor B1IBA
08/2005
1HLA-DRB1 Chains (HLA DRB1)IBA
08/2005
1HLA-A*26:01 antigenIBA
05/2005
1Concanavalin AIBA
08/2003
1Complement System Proteins (Complement)IBA
08/2003
1Monoclonal AntibodiesIBA
08/2003
1IntegrinsIBA
08/2003
1HLA-A*33 antigenIBA
06/2003

Therapy/Procedure

2Immunotherapy
06/2006 - 11/2002
1Therapeutics
01/2021
1Hematopoietic Stem Cell Transplantation
03/2009